Carvedilol
Product Images NDC 10135-634

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 10135-634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structure Formula For Carvedilol Is A Nonselective β-adrenergic Blocking Agent With α1-blocking Activity. It Is (±)-1-(carbazol- 4-yloxy)-3-[[2-(o-methoxyphenoxy) Ethyl] Amino]-2-propanol. (Carvedilol 01)

Chemical structure of Carvedilol showing its molecular framework including a carbazole moiety and an ether-linked side chain with hydroxyl, amino, and methoxy functional groups.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol 02)

A line graph depicting percent mortality over 21 months comparing Carvedilol and placebo. The graph shows lower mortality rates for Carvedilol relative to placebo with statistical significance indicated by P = 0.0014.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol 03)

A forest plot showing hazard ratios with confidence intervals for various subgroups, including gender, age, race, diabetes status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, as well as all patients combined. The x-axis represents hazard ratio values ranging from 0.0 to 2.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol 04)

A line graph showing percent mortality over 24 months comparing Carvedilol and Placebo. The y-axis represents % mortality from 0 to 30, and the x-axis represents time in months from 0 to 24. The graph includes a p-value of 0.03 indicating statistical significance between the two lines.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol 05)

A forest plot displaying hazard ratios with confidence intervals for various patient subgroups. The subgroups include age, gender, randomization timing post myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy status, PTCA for myocardial infarction, CHF status, diuretic use during MI, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The x-axis represents the hazard ratio scale from 0.4 to 1.3.*

FDA Label Image

Principal Display Panelndc 10135-0633-01carvedilol Tablets Usp3.125 mg100 Tabletsrx Only (Carvedilol 06)

Carvedilol Tablets USP 3.125 mg label from Marlex Pharmaceuticals, Inc. The label shows a package size of 100 tablets, specifies that the product is Rx only, and includes storage instructions. Manufactured by Beximco Pharmaceuticals Ltd and distributed by Marlex Pharmaceuticals, Inc.*

FDA Label Image

Principal Display Panelndc 10135-0634-01carvedilol Tablets Usp6.25 mg100 Tabletsrx Only (Carvedilol 07)

Carvedilol Tablets USP 3.125 mg label from Marlex Pharmaceuticals Inc. The label shows a 500 tablets package size. It includes storage instructions, manufacturer Beximco Pharmaceuticals Ltd, and distributor information for Marlex Pharmaceuticals, Inc. The label displays the National Drug Code (NDC) 10135-0633-05 and indicates the product is Rx only.*

FDA Label Image

Principal Display Panelndc 10135-0635-01carvedilol Tablets Usp12.5 mg100 Tabletsrx Only (Carvedilol 08)

Carvedilol Tablets USP 6.25 mg label from Marlex Pharmaceuticals Inc. The label displays the dosage strength, Rx only designation, and a package size of 100 tablets. The label notes the manufacturer as Beximco Pharmaceuticals Ltd and includes storage instructions and barcode.*

FDA Label Image

Principal Display Panelndc 10135-0637-01carvedilol Tablets Usp25 mg100 Tabletsrx Only (Carvedilol 09)

Carvedilol Tablets USP 6.25 mg label from Marlex Pharmaceuticals Inc. The label indicates the product contains 500 tablets marked Rx Only. The manufacturer is Beximco Pharmaceuticals Ltd. Storage information, dosage instructions directing to package insert, and a barcode are also visible.*

FDA Label Image

Carvedilol 0a

Carvedilol Tablets USP 12.5 mg label from Marlex Pharmaceuticals, Inc. This label indicates the product contains 100 tablets for prescription use. The label also includes storage instructions and manufacturer information for Beximco Pharmaceuticals Ltd., with a barcode on the right side.*

FDA Label Image

Carvedilol 0b

Carvedilol Tablets USP 12.5 mg label with NDC 10135-0635-05. The label shows the product name, strength 12.5 mg, and quantity of 500 tablets. Manufactured by Beximco Pharmaceuticals Ltd. and distributed by Marlex Pharmaceuticals Inc. Storage instructions and barcode are also visible.*

FDA Label Image

Carvedilol 0c

Carvedilol 25 mg tablets label from Marlex Pharmaceuticals Inc. The packaging indicates 100 tablets, Rx only. The label includes dosage strength, storage instructions, and manufacturer information for Beximco Pharmaceuticals Ltd. Barcode and NDC 10135-0637-01 are visible.*

FDA Label Image

Carvedilol 0d

Label for Carvedilol Tablets USP 25 mg by Marlex Pharmaceuticals Inc. The label indicates 500 tablets, prescription only. It includes storage instructions, manufacturer (Beximco Pharmaceuticals Ltd.), and distributor information. The label design features a blue and white color scheme with a barcode on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.